These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 11249775
1. The evolution of DNA vaccines. Apostolopoulos V, Plebanski M. Curr Opin Mol Ther; 2000 Aug; 2(4):441-7. PubMed ID: 11249775 [Abstract] [Full Text] [Related]
2. [Novel vaccines against M. tuberculosis]. Okada M. Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [Abstract] [Full Text] [Related]
3. DNA vaccines and their application against parasites--promise, limitations and potential solutions. Smooker PM, Rainczuk A, Kennedy N, Spithill TW. Biotechnol Annu Rev; 2004 Dec; 10():189-236. PubMed ID: 15504707 [Abstract] [Full Text] [Related]
4. Current progress of DNA vaccine studies in humans. Lu S, Wang S, Grimes-Serrano JM. Expert Rev Vaccines; 2008 Mar; 7(2):175-91. PubMed ID: 18324888 [Abstract] [Full Text] [Related]
11. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization? Hoffman SL, Doolan DL. Dev Biol (Basel); 2000 Sep; 104():121-32. PubMed ID: 11713810 [Abstract] [Full Text] [Related]
12. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Bodles-Brakhop AM, Draghia-Akli R. Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956 [Abstract] [Full Text] [Related]
13. Nucleic acid vaccines. Cernescu C. Rom J Virol; 1995 Sep; 46(1-2):69-73. PubMed ID: 9106403 [Abstract] [Full Text] [Related]
14. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines. Kim SJ, Sung HW, Han JH, Jackwood D, Kwon HM. Vet Microbiol; 2004 Jun 10; 101(1):39-51. PubMed ID: 15201032 [Abstract] [Full Text] [Related]
15. DNA vaccines: successes and limitations in cancer and infectious disease. Lowe DB, Shearer MH, Kennedy RC. J Cell Biochem; 2006 May 15; 98(2):235-42. PubMed ID: 16440328 [Abstract] [Full Text] [Related]
16. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Hwang C, Sanda MG. Curr Opin Mol Ther; 1999 Aug 15; 1(4):471-9. PubMed ID: 11713762 [Abstract] [Full Text] [Related]
18. DNA for genetic vaccination and therapy. Moelling K. Cytokines Cell Mol Ther; 1997 Jun 15; 3(2):127-35. PubMed ID: 9287251 [Abstract] [Full Text] [Related]
20. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. Epstein JE, Charoenvit Y, Kester KE, Wang R, Newcomer R, Fitzpatrick S, Richie TL, Tornieporth N, Heppner DG, Ockenhouse C, Majam V, Holland C, Abot E, Ganeshan H, Berzins M, Jones T, Freydberg CN, Ng J, Norman J, Carucci DJ, Cohen J, Hoffman SL. Vaccine; 2004 Apr 16; 22(13-14):1592-603. PubMed ID: 15068840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]